But, I will argue that Hem is more than a bonus--presently siRNA will not work for all cancers. So, what siRNA will not silence, stem cell therapy will. They compliment one another. Don't sell Hem too short.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.